Resolves YES if, before January 1, 2031, a credible report shows that a company earned >= $50M USD in revenue attributable to biological-computing products or services in a year.

Note:

• A year = Over a fiscal year or over any trailing 12-month period of actual (not projected or run rate) revenue.

• Report must be published before Jan 1, 2031. (e.g. FY2030 report released in early 2031 does not count).

• Resolves NO if January 1, 2031 passes with no such report.

• For a company whose primary business is biological computing, total company revenue counts. For any other company, only the segment it explicitly discloses as biological-computing revenue counts.

What count as biological computing:

• living-neuron/organoid systems (e.g. Cortical Labs, FinalSpark).

What doesn't count:

• DNA/molecular data storage, synthetic biology logic circuits used purely as biosensors, and neuromorphic silicon chips.